The goal of this comparative, interventional randomized controlled trial is to use albumin during resuscitation in pediatric burn patients on day 2, as it can reduce extravasation of fluids and decrease the overall fluid requirements, along with mortality and maintain circulation. Participants will be divided into 2 groups. Albumin will be administered additionally in group A, while only crystalloids will be used for resuscitation in group B.
The randomized controlled trial will be done at Department of Pediatric Surgery, Mayo Hospital Lahore from January 2022 to December 2022. Ninety patients (forty-five patients in each group) will be enrolled using a non probability convenient sampling technique. Patients will be randomly divided into 2 groups. Albumin solution will be administered in group A and in group B only routine crystalloids will be given. Basic demographic information will be noted. Effect modifiers (hemoglobin, Albumin level, weight and height) will be noted. Group A: After first 24 hours, maintenance fluid, N/2+5%Dextrose solution will be started according to weight(100ml/kg/day for first 10kg, 50ml/kg/day for next 10kg and 20ml/kg/day for the remainder) and will be increased or decreased by 1/3 to maintain the urinary output to 1-1.5ml/kg/hour. 12, 75 5% Albumin solution will be administered @0.5ml/kg/%burn over initial 8 hours of day 2 and It's amount will be subtracted from the 24 hours fluid calculated earlier. Group B: After first 24 hours, maintenance fluid, N/2+5%Dextrose solution will be started according to weight (100ml/kg/day for first 10kg, 50ml/kg/day for next 10kg and 20ml/kg/day for the remainder) and will be increased or decreased by 1/3 to maintain the urinary output to 1-1.5ml/kg/hour.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
90
Albumin is a biological product derived from human blood donors.
Paeds solution contains dextrose 4.3%, and Sodium Chloride 0.18%
King Edward Medical University, Mayo Hospital
Lahore, Punjab Province, Pakistan
Resuscitation Volume
Total volume of fluid required to maintain a urine output of 1-1.5ml/hour on the day 2 of admission.
Time frame: 24-48 hours
Serum Albumin levels
Albumin level in patient after day 2 of admission
Time frame: 24-48 hours
Urine Output
Amount of urine passed on day 2 of admission. Should be 1-2.5ml/kh/hr
Time frame: 24-48 hours
Requirement of inotropic support
Patients in shock not responding to additional fluid administration, with reduced urine output requiring dopamine or dobutamine.
Time frame: 24-48 hours
Mortality
Any death occuring within 5 days of admission
Time frame: First 5 days of admission
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.